MPN

What endpoints did aspirin prophylaxis reach for most essential thrombocytosis patients in clinical trials ?
Reduction in non-fatal myocardial infarction, stroke, pulmonary embolism, deep venous thrombosis
But no change in overall survival

en_USEnglish